
| Upcoming Event | |||||
|---|---|---|---|---|---|
|
Jan 15, 2009 11:00 AM PT |
J.P. Morgan 27th Annual Healthcare Conference
|
||||
| Archived Events | |||||
|---|---|---|---|---|---|
|
Nov 18, 2008 8:55 AM ET |
Lazard Capital Markets 5th Annual Healthcare Conference
|
||||
|
Nov 12, 2008 9:55 AM ET |
Rodman & Renshaw 10th Annual Healthcare Conference
|
||||
|
Oct 6, 2008 9:00 AM ET |
Dendreon Conference Call - Interim Results of IMPACT Trial
|
||||
|
Aug 12, 2008 4:30 PM ET |
Dendreon Corporation Second Quarter 2008 Financial Results
|
||||
|
Mar 13, 2008 8:00 AM PT |
Dendreon Corporation Fourth Quarter 2007 Financial Results
|
||||
| Nicole Provost, Ph.D., vice president of product development, recently presented the results of potency testing for PROVENGE at the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee Meeting. The purpose of the committee meeting was to discuss Potency Measurement for Cell and Gene Therapy Products. The full presentation is available at the following links: Slides Meeting Transcript |